Journal of Lipid Research, Vol 31, 1141-1146, Copyright © 1990 by Lipid Research, Inc.

ARTICLES

A solution hybridization/RNase protection assay with riboprobes to determine absolute levels of apoB, A-I, and E mRNA in human hepatoma cell lines

N Azrolan and JL Breslow
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, NY 10021.

A solution hybridization/RNase protection assay with riboprobes was developed to quantitate apolipoprotein mRNA concentrations. Previously, radiolabeled DNA probes have been used in solution hybridization/S1 nuclease protection assays for this purpose. The new assay requires less time for probe preparation and hybridization compared to previous assays. In addition, the vector used for riboprobe preparation can also be used to conveniently produce cRNA required to generate the standard curve to quantitate absolute apolipoprotein mRNA levels. The solution hybridization RNase protection assay was used to quantitate apoB, A-I, and E mRNA levels in four human hepatoma cell lines, HepG2, Hep3B, WRL- 68, SK-Hep2. HepG2 and Hep3B, but not WRL-68 and SK-Hep2 cells had concentrations of all three apolipoprotein mRNAs comparable to liver in vivo. These data suggest that HepG2 and Hep3B are suitable models to study liver specific apolipoprotein gene expression.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. J. Wilcox, N. M. Borradaile, L. E. de Dreu, and M. W. Huff Secretion of hepatocyte apoB is inhibited by the flavonoids, naringenin and hesperetin, via reduced activity and expression of ACAT2 and MTP J. Lipid Res., May 1, 2001; 42(5): 725 - 734. [Abstract] [Full Text]

				A. Theriault, Q. Wang, S. C. Van Iderstine, B. Chen, A. A. Franke, and K. Adeli Modulation of hepatic lipoprotein synthesis and secretion by taxifolin, a plant flavonoid J. Lipid Res., December 1, 2000; 41(12): 1969 - 1979. [Abstract] [Full Text]

				J. R. Burnett, L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs J. Lipid Res., July 1, 1999; 40(7): 1317 - 1328. [Abstract] [Full Text]

				L. J. Wilcox, P. H. R. Barrett, and M. W. Huff Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin J. Lipid Res., June 1, 1999; 40(6): 1078 - 1089. [Abstract] [Full Text]

				H.-S. Kim, N. Maeda, G. T. Oh, L. G. Fernandez, R. A. Gomez, and O. Smithies Homeostasis in Mice with Genetically Decreased Angiotensinogen Is Primarily by an Increased Number of Renin-producing Cells J. Biol. Chem., May 14, 1999; 274(20): 14210 - 14217. [Abstract] [Full Text] [PDF]

				L. J. Wilcox, P. H. R. Barrett, R. S. Newton, and M. W. Huff ApoB100 Secretion From HepG2 Cells is Decreased by the ACAT Inhibitor CI-1011 : An Effect Associated With Enhanced Intracellular Degradation of ApoB Arterioscler. Thromb. Vasc. Biol., April 1, 1999; 19(4): 939 - 949. [Abstract] [Full Text] [PDF]

				K. Reue mRNA Quantitation Techniques: Considerations for Experimental Design and Application J. Nutr., November 1, 1998; 128(11): 2038 - 2044. [Full Text]

				J. R. Burnett, L. J. Wilcox, D. E. Telford, S. J. Kleinstiver, P. H. R. Barrett, R. S. Newton, and M. W. Huff Inhibition of HMG-CoA Reductase by Atorvastatin Decreases Both VLDL and LDL Apolipoprotein B Production in Miniature Pigs Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2589 - 2600. [Abstract] [Full Text]

				H. C.F. Oliveira, R. A. Chouinard, L. B. Agellon, C. Bruce, L. Ma, A. Walsh, J. L. Breslow, and A. R. Tall Human Cholesteryl Ester Transfer Protein Gene Proximal Promoter Contains Dietary Cholesterol Positive Responsive Elements and Mediates Expression in Small Intestine and Periphery While Predominant Liver and Spleen Expression Is Controlled by 5'-distal Sequences. CIS-ACTING SEQUENCES MAPPED IN TRANSGENIC MICE J. Biol. Chem., December 13, 1996; 271(50): 31831 - 31838. [Abstract] [Full Text] [PDF]

				E. G. Shesely, N. Maeda, H.-S. Kim, K. M. Desai, J. H. Krege, V. E. Laubach, P. A. Sherman, W. C. Sessa, and O. Smithies Elevated blood pressures in mice lacking endothelial nitric oxide synthase PNAS, November 12, 1996; 93(23): 13176 - 13181. [Abstract] [Full Text] [PDF]

				D. T. Berg, D. S. Calnek, and B. W. Grinnell Trans-repressor BEF-1 Phosphorylation J. Biol. Chem., March 1, 1996; 271(9): 4589 - 4592. [Abstract] [Full Text] [PDF]

				N. Azrolan, H. Odaka, J. L. Breslow, and E. A. Fisher Dietary Fat Elevates Hepatic ApoA-I Production by Increasing the Fraction of Apolipoprotein A-I mRNA in the Translating Pool J. Biol. Chem., August 25, 1995; 270(34): 19833 - 19838. [Abstract] [Full Text] [PDF]

				J. G. Bisaha, T. C. Simon, J. I. Gordon, and J. L. Breslow Characterization of an Enhancer Element in the Human Apolipoprotein C-III Gene That Regulates Human Apolipoprotein A-I Gene Expression in the Intestinal Epithelium J. Biol. Chem., August 25, 1995; 270(34): 19979 - 19988. [Abstract] [Full Text] [PDF]

				D. T. Berg, D. S. Calnek, and B. W. Grinnell The Human Apolipoprotein E Gene Is Negatively Regulated in Human Liver HepG2 Cells by the Transcription Factor BEF-1 J. Biol. Chem., June 30, 1995; 270(26): 15447 - 15450. [Abstract] [Full Text] [PDF]